HIM
AGN

Hanlon Investment Management’s Allergan plc AGN Stock Holding History

Hanlon Investment Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-9,684
Closed -$2.31M – 126
2017
Q1 		$2.31M Buy
+9,684
New +$2.26M 0.29% 88

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Hanlon Investment Management's AGN Position: Q2 2017 in Review

Hanlon Investment Management sold out of Allergan plc (AGN) in Q2 2017, closing a stake of 9,684 shares — an estimated $2.31M sold.

Hanlon Investment Management first reported a position in AGN in Q1 2017 and held it in 1 quarter. The position peaked at $2.31M in Q1 2017. 1,115 funds tracked by Wall St. Rank hold AGN as of Q2 2017.

  • Hanlon Investment Management reported no remaining Allergan plc position as of Q2 2017 after selling out during the quarter.
  • Hanlon Investment Management sold 9,684 Allergan plc shares in Q2 2017, an estimated $2.31M.
  • Hanlon Investment Management first reported a position in Allergan plc in Q1 2017 and held it in 1 quarter.
  • Hanlon Investment Management's Allergan plc position peaked at $2.31M in Q1 2017.
  • 1,115 funds tracked by Wall St. Rank held Allergan plc as of Q2 2017.

Based on Hanlon Investment Management's 13F filing for Q2 2017, filed 11 Aug 2017.